1‐(4‐Methyl­piperdinemeth­yl)‐2‐(4‐bromo­phen­yl)‐6‐meth­yl‐8‐trifluoromethyl­imidazo[1,2‐a][1,8]naph­thyridinium picrate

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-5368|61|5|o1377-o1380

ISSN： 1600-5368

Source： Acta Crystallographica Section E, Vol.61, Iss.5, 2005-05, pp. : o1377-o1380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

4‐(4‐Bromo­phen­yl)‐3‐(2,5‐dioxopyrrolidin‐1‐yl)‐1‐(4‐methyl­oxyphen­yl)azetidin‐2‐one

By  

Acta Crystallographica Section E, Vol. 62, Iss. 10, 2006-10 ,pp. : o4487-o4488

John Wiley & Sons Inc

Access to resources Recommend Favorite

1‐{[2‐(Bromo­meth­yl)‐2‐(4‐chloro­phen­yl)‐1,3‐dioxolan‐4‐yl]meth­yl}‐1H‐1,2,4‐triazole

By  

Acta Crystallographica Section E, Vol. 62, Iss. 6, 2006-06 ,pp. : o2183-o2184

John Wiley & Sons Inc

Access to resources Recommend Favorite

1‐Methyl‐2‐(4‐nitro­phen­yl)imidazo[1,2‐a]pyridinium perchlorate: a powder study

By  

Acta Crystallographica Section E, Vol. 63, Iss. 4, 2007-04 ,pp. : o1861-o1863

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐(4‐Bromo­phen­yl)‐1H‐benzimidazole

By  

Acta Crystallographica Section E, Vol. 63, Iss. 3, 2007-03 ,pp. : o1260-o1261

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐(5‐Bromo‐2‐methyl‐4‐nitro­imidazol‐1‐yl)‐1‐(2‐chloro­phen­yl)ethanone

By  

Acta Crystallographica Section E, Vol. 63, Iss. 4, 2007-04 ,pp. : o1669-o1671

John Wiley & Sons Inc

Access to resources Recommend Favorite